Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
Ken Kato(National Cancer Center Hospital East), Byoung Chul Cho(Yonsei University), Masanobu Takahashi(Tohoku University Hospital), Morihito Okada(Hiroshima University Hospital), Chen-Yuan Lin(China Medical University Hospital), Keisho Chìn(Japanese Foundation For Cancer Research), Shigenori Kadowaki(Aichi Cancer Center), Myung‐Ju Ahn(Samsung Medical Center), Yasuo Hamamoto(Keio University), Yuichiro� Doki(Osaka University Hospital), Chueh‐Chuan Yen(National Yang Ming Chiao Tung University), Yutaro Kubota(Showa University Hospital), Sung‐Bae Kim(Ulsan College), Chih‐Hung Hsu(National Taiwan University Hospital), Eva Holtved(Odense University Hospital), Ioannis Xynos(Bristol-Myers Squibb (United States)), Mamoru Kodani(Ono Pharmaceutical (Japan)), Yuko Kitagawa(Keio University)
Cited by 1,225Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis